Alyeska Investment Group L.P. Has $65.64 Million Stock Position in Mirion Technologies, Inc. (NYSE:MIR)

Alyeska Investment Group L.P. cut its holdings in Mirion Technologies, Inc. (NYSE:MIR - Free Report) by 51.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,761,315 shares of the company's stock after selling 4,057,311 shares during the quarter. Alyeska Investment Group L.P. owned about 1.62% of Mirion Technologies worth $65,635,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the company. US Bancorp DE raised its position in shares of Mirion Technologies by 3,248.7% during the 4th quarter. US Bancorp DE now owns 6,262 shares of the company's stock valued at $109,000 after acquiring an additional 6,075 shares during the last quarter. Tower Research Capital LLC TRC raised its stake in shares of Mirion Technologies by 162.9% during the fourth quarter. Tower Research Capital LLC TRC now owns 6,649 shares of the company's stock valued at $116,000 after acquiring an additional 4,120 shares during the last quarter. Harvest Fund Management Co. Ltd bought a new position in shares of Mirion Technologies in the 4th quarter worth about $120,000. KBC Group NV increased its position in shares of Mirion Technologies by 39.2% during the fourth quarter. KBC Group NV now owns 8,002 shares of the company's stock worth $140,000 after acquiring an additional 2,254 shares in the last quarter. Finally, Corient Private Wealth LLC bought a new position in shares of Mirion Technologies in the fourth quarter valued at approximately $187,000. Institutional investors own 78.51% of the company's stock.

Analyst Upgrades and Downgrades

MIR has been the topic of a number of research analyst reports. B. Riley reduced their target price on Mirion Technologies from $19.00 to $17.00 and set a "buy" rating on the stock in a research note on Wednesday, April 16th. Citigroup lowered their target price on shares of Mirion Technologies from $20.00 to $17.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Finally, Robert W. Baird reduced their target price on shares of Mirion Technologies from $22.00 to $20.00 and set an "outperform" rating for the company in a report on Friday, April 4th. Four equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Buy" and an average target price of $18.75.

Mirion Technologies Price Performance

Mirion Technologies stock traded up $0.19 during trading hours on Thursday, hitting $16.29. The stock had a trading volume of 246,743 shares, compared to its average volume of 1,676,858. The stock's fifty day moving average is $14.56 and its two-hundred day moving average is $15.70. Mirion Technologies, Inc. has a 1-year low of $9.11 and a 1-year high of $18.81. The stock has a market capitalization of $3.79 billion, a price-to-earnings ratio of -85.74 and a beta of 0.74. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.16 and a quick ratio of 1.55.

Mirion Technologies (NYSE:MIR - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $0.10 earnings per share for the quarter, topping analysts' consensus estimates of $0.08 by $0.02. The company had revenue of $202.00 million during the quarter, compared to analyst estimates of $199.34 million. Mirion Technologies had a negative net margin of 4.21% and a positive return on equity of 4.78%. The business's revenue for the quarter was up 4.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.06 EPS. As a group, analysts predict that Mirion Technologies, Inc. will post 0.39 earnings per share for the current fiscal year.

About Mirion Technologies

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.